cysteamine chemical compound biosynthesized mammals including humans degradation coenzyme intermediate pantetheine broken cysteamine pantothenic biosynthetic precursor neurotransmitter stable aminothiol ie organic compound containing amine thiol functional groups cysteamine white watersoluble solid often used salts ammonium derivative including hydrochloride phosphocysteamine medication cysteamine sold brand name cystagon among others indicated treat cystinosis lysosomal storage disease characterized abnormal accumulation cystine oxidized dimer amino acid removes excessive cystine builds cells people available mouth capsule extended release capsule eye applied topically scavenge free lighten skin thats darkened result postinflammatory hyperpigmentation sun exposure tentative evidence suggests may effective depigmentation agent hydroquinone retinoids topical corticosteroids individuals chronic skin topical application cysteamine cream also demonstrated similar efficacy intradermal tranexamic acid injections treatment melasma much fewer adverse important adverse effect related topical use might skin irritationmedical citation needed however significantly better tolerated alternative skin lightening treatments similar label oral formulations cysteamine carry warnings symptoms similar ehlersdanlos syndrome severe skin rashes ulcers bleeding stomach intestines central nervous symptoms including seizures lethargy somnolence depression encephalopathy low white blood cell levels elevated alkaline phosphatase idiopathic intracranial hypertension cause headache tinnitus dizziness nausea double blurry vision loss vision pain behind eye pain eye additional adverse effects oral cysteamine include bad breath skin odor vomiting nausea stomach pain diarrhea loss drug pregnancy category c risks cysteamine fetus known harms babies animal models doses less given eye drops common adverse effects sensitivity light redness eye pain headache visual field drug interactions normal capsules eye extended release capsules taken drugs affect stomach acid like proton pump inhibitors alcohol cause drug released doesnt inhibit cytochrome people cystinosis lack functioning transporter cystinosin transports cystine lysosome cytosol ultimately leads buildup cystine lysosomes crystallizes damages cysteamine enters lysosomes converts cystine cysteine cysteinecysteamine mixed disulfide exit cysteamine also promotes transport lcysteine cells used synthesize glutathione one potent intracellular first evidence regarding therapeutic effect cysteamine cystinosis dates back cysteamine first approved drug cystinosis us extended release form approved approved us food drug administration fda european medicines agency regular capsule cysteamine cost per year extended release form introduced year priced per studied vitro animal models radiation protection similar models onwards sickle cell anemia effects growth ability modulate immune system possible inhibitor tested clinical trials paracetamol toxicity failed clinical trials systemic lupus erythematosus early also clinical trials huntingtons disease begun ongoing clinical trials parkinsons disease malaria radiation sickness neurodegenerative disorders neuropsychiatric disorders cancer update studied clinical trials pediatric nonalcoholic fatty liver httpsenwikipediaorgwikicysteamine